tion due to hypoxia. 13 Infection, in turn, can predispose the wound to breakdown and dehiscence. Late radiation effects include dermal fibrosis and atrophy, as well as vascular fibrosis from intimal thickening, which results in reduced vascularity and tissue hypoxia. Although less commonly studied, a distant history of radiation treatment could theoretically increase wound complications due to these late sequelae.
Methods

Study Population
Institutional and departmental databases were used to identify patients who underwent radiation therapy and spine surgery at Memorial Sloan-Kettering Cancer Center (MSKCC) between January 1999 and June 2010. The use of hypofractionated IGRT for paraspinal tumors at MSKCC began in 2003. All surgeries evaluated in this study were related to the management of spinal metastases. We retrospectively reviewed medical records of patients over 18 years of age who received radiation therapy to the spine and who subsequently underwent spine surgery to the same site. The Institutional Review Board of MSKCC approved this study.
To be eligible for study inclusion, patients must have received at least 9 Gy of the radiation treatment course that had been prescribed. Patients with previous radiation close to an adjacent spinal level or partial radiation field overlap into the operative site were excluded. Patients could not have received a second course of preoperative radiation therapy delivered to the same site, but could have received a second course of radiation therapy postoperatively to the same site. For inclusion in the study, patients could have had multiple noncontiguous sites of paraspinal metastases, extraspinal metastases, prior history of surgery involving the same site, or a prior history of radiation therapy to a site that was not overlapping or immediately adjacent.
In total, 165 patients with 165 surgical wounds met inclusion criteria and had received either XRT or hypofractionated IGRT. Of the 165 patients included in the study, 130 patients received preoperative XRT and 35 patients received preoperative hypofractionated IGRT. For this study, conventional fractionation was defined as ≤300 cGy per treatment in 1-2 fields with rare exceptions, and hypofractionated IGRT was defined as > 300 cGy per treatment using conformal, image-guided techniques. Of the 165 patients, 4 patients had received radiation to 2 or 3 separate sites within the subsequent surgical bed. For these patients, only the first site of radiation was included in the analysis.
Clinical Characteristics
Patient demographic and clinical characteristics are detailed in Table 1 . The Karnofsky Performance Scale (KPS) score was noted if documented within 2 weeks of surgery. Body mass index (BMI) was calculated using the Quetelet Index formula (mass [kg] / height [m] 2 ), if weight was recorded within 1 week of surgery. Overweight was defined as BMI ≥ 25. Tobacco use was categorized as never smoker, current smoker, or past smoker. Patients were categorized as having had prior vertebroplasty or kyphoplasty if these procedures occurred at the same site of spinal radiation and surgery. A patient had multiple spinal metastases if there were 2 or more regions of noncontiguous spine metastasis observed on imaging. Extraspinal disease included any site of metastasis outside of the spinal axis.
Tumor histologies of the spine metastases of all study patients are listed in Table 2 . Pathological review of tissue specimens from spine surgery was routinely performed. Hematological malignancies were included in this study because the study end point was wound complication rather than tumor control.
Preoperative ambulatory status was categorized as nonambulatory, ambulatory with assistance, or ambulatory without assistance. Preoperative hemoglobin, total lymphocyte count, and albumin levels within 1 week of surgery were evaluated. Serum albumin < 4 g/dl was considered indicative of protein depletion. A total lymphocyte count of < 900 cells/mm 3 was used as the cutoff point because this level reflects immune compromise and significant nutritional depletion.
Systemic therapy was defined as chemotherapy administered 30 days before through 30 days after surgery, and did not include treatment with biological agents or hormone therapy. Perioperative corticosteroid use was defined as administration of dexamethasone during the period of 7 days before to 7 days after surgery, but did include 1 patient who had been receiving chronic high-dose prednisone after an allogeneic peripheral-blood, stemcell transplant in the same defined time period.
Surgery
Surgery was indicated to prevent onset or progression of neurological deficits, palliation of pain not alleviated by optimal conservative management, vertebral body collapse, treatment of radioresistant tumor histology, and mechanical instability. An estimated life expectancy of approximately 3-6 months was a general prerequisite for surgery. Patients typically underwent a single-stage surgery with decompression and spinal fixation, usually with a posterolateral, transpedicular approach. Three patients underwent surgery with a solely anterior approach, and no patients underwent surgery with a combined anterior/ posterior approach. Long posterior fixation typically involved a minimum of 2 levels superior and inferior to the level of the decompression. Prophylactic antibiotics were given at the induction of anesthesia and continued until drains were discontinued, typically on postoperative Day 3. The mean hospital stay following surgery was 5 days and staples were removed at 3 weeks. Previous spine surgery to the same or other noncontiguous spinal location was noted. The spinal region of tumor location was classified as cervical, cervicothoracic, thoracic, thoracolumbar, lumbar, or lumbosacral. The surgical approach, use of stabilization hardware, number of vertebral body segments spanned by hardware, spinal region of instrumentation (occipitocervical, subaxial cervical, cervicothoracic, thoracic, thoracolumbar, lumbar, or lumbosacral), graft use, and type of graft if applicable were also noted. Postoperative nonwound complications were defined as those occurring within 30 days of surgery.
Wound Complication Treatment
Wound infection was defined by a combination of erythema and purulent drainage. Wounds with purulent drainage were surgically debrided. When patients required an operative wound revision, they underwent open surgical debridement generally followed by a rotational muscle flap that was performed by the plastic surgery service. The origin of the muscle flap was determined by the level of the wound. Patients with minor wound dehiscences without purulent discharge or positive cultures were treated with wound packing or wet to dry dressings.
Radiation Therapy
Patients who received conventional palliative radiation were generally treated with a 2D technique that did not require a treatment plan. Radiation fields typically included at least 1 vertebral body superior and inferior to the vertebral bodies targeted for treatment. Following conventional palliative radiation, patients were typically observed in follow-up with radiation oncology on an asneeded basis. A total of 19 patients received conventional palliative radiation preoperatively at an outside hospital and not at MSKCC. All IGRT patients in this study were treated at MSKCC. Image-guided radiation therapy was performed using linear accelerator gantry-mounted cone beam CT with Memorial body cradle immobilization.
Computed tomography target delineation was performed by the treating radiation oncologist with input from the treating neurosurgeon (M.H.B.). Gross tumor volume was defined as radiographically identifiable tumor. For tumors involving the vertebral body, the clinical target volume included the gross tumor volume and generally the entire vertebral body. The posterior elements were included in the clinical target volume if they were involved with tumor. The planning target volume (PTV) was created by expanding the clinical target volume with a 3D margin of 3 mm. However, this expanded PTV was never allowed to violate the spinal cord contour, such that areas close to the spinal cord (such as an epidural extension) would not have a 3-mm margin. Seven to 9 coplanar beams with dynamic multileaf collimation were typically used, delivering 6 MV and/or 15 MV photons.
The total treatment dose to the PTV ranged from 18 Gy to 30 Gy, delivered over 1-5 fractions. Specifically, treatment regimens included the following: 6 Gy × 5 fractions delivered on consecutive days, 8 or 9 Gy × 3 fractions delivered every other day, and 18, 21, or 24 Gy delivered in 1 single fraction. Patients treated before 2006 with single-fraction radiation were prescribed 18 Gy to the PTV and 20 Gy to the gross tumor volume using a dose-painting technique. This earlier treatment approach was subsequently replaced by a dose of 21 Gy to the PTV, and then 24 Gy prescribed to the PTV in a single fraction without dose painting. For single-fraction treatments, the maximum point doses allowed to the spinal cord and cauda equina were 12-14 Gy and 16 Gy, respectively. For 8 Gy × 3 fraction regimens without previous radiation, the maximum total point dose allowed to spinal cord and cauda equina was 24 Gy. For 6 Gy × 5 fraction regimens without previous radiation, the maximum total point doses to spinal cord and cauda equina were 25 Gy and 30 Gy, respectively. After completion of therapy, patients were typically observed in follow-up at 2 months, and then every 3-4 months. An MR image of the total spine was obtained at the time of each follow-up visit.
For both XRT and IGRT patients in this study, the length of time between preoperative radiation therapy and surgery was calculated from the date that radiation was completed to the date of surgery. Follow-up for all patients was performed through December 2010. The date of last follow-up was defined by the date of death for deceased patients and by the last date of documented clinical follow-up for survivors.
Statistical Analysis
Clinical, tumor, surgical, and radiation treatment characteristics were compared between the XRT and IGRT groups using the Student t-test, Wilcoxon rank-sum test, chi-square analysis, and Fisher's exact test, as appropriate. When necessary, potential predictors that were continuous variables were categorized as dichotomous variables by the median value or according to a cut-off value of clinical significance.
The study end point was defined as time to wound complication. For this study, wound complication was defined as delayed healing, infection, and dehiscence. The time to wound complication was calculated from the date of surgery to the date the event was first documented in the medical record, last clinical follow-up for survivors who did not experience the event, or date of death for those who died and did not experience the event.
The potential association of various clinical, tumor, surgical, and radiation treatment factors with the development of postoperative wound complication was evaluated. Due to the frequent occurrence of death expected during the follow-up period in this patient population with metastatic disease, univariate analyses using competing-risk methods were used to identify factors related to the occurrence of wound complication, while adjusting for the competing risk of death without wound complication. Competing-risk methods were used because death could not be assumed to be independent of event occurrence. Competing-risk analysis was performed with the R statistical program (version 2.9) using the "crr" and "cuminc" functions within the library "cmprsk." All other statistical analyses were performed using SAS 9.2 (SAS Institute).
Results
Patient Characteristics
The XRT and IGRT patient groups had comparable baseline characteristics (Table 3 ). The only significant differences between the groups were the number of vertebral bodies targeted for radiation treatment and the presence of multiple noncontiguous spine metastases. The XRT and IGRT groups had a mean of 4.6 and 1.8 vertebral bodies in the treatment field, respectively (p < 0.0001). Among the XRT group, 47% had multiple contiguous spine metastases, whereas 26% of the IGRT group did (p = 0.02). The mean total lymphocyte count was 0.7 × 10 3 cells/μl in the XRT group and 0.9 × 10 3 cells/μl in the IGRT group, which showed a trend toward significance (p = 0.07). Although the presence of multiple noncontiguous spine metastases was 45% in the XRT group and 31% in the IGRT group, the difference was not significant (p = 0.14).
Among the XRT patients, the most common tumor histologies were renal carcinoma (19%), breast (16%), prostate (14%), and lung (12%), whereas in the IGRT group they were renal (29%), lung (14%), sarcoma (11%), and melanoma (11%). In the XRT group, the most common sites of spine metastasis were thoracic (42%), lumbar (23%), and thoracolumbar (18%). For the IGRT patients, they were thoracic (51%), lumbar (31%), cervical (6%), and cervicothoracic (6%).
The median age at the time of surgery was 62 years for the entire patient cohort, and was 62 years (range 26-84 years) for the XRT group and 60 years (range 43-82 years) for the IGRT group. The median KPS score was 70 (range 60-100). Preoperative KPS score was documented in the medical record for 50% of all patients. Perioperative steroids were administered to 93% of all study patients. A posterior surgical approach was used for 98% of patients, with an anterior approach used for the remaining 2%. Spinal stabilization hardware was placed in 93% of study patients. Table 4 lists the frequencies of different dose-perfraction regimens used for XRT and IGRT treatments in the study group. Dose-per-fraction data were missing for 2 XRT patients. For the XRT group, the median total treatment dose was 30 Gy, with a range of 11.5 to 70 Gy. The most common treatment regimen was 10 × 3 Gy, which was used for 93 patients (72%), followed by 12 × 2.5 Gy received by 8 patients (6%), and 15 × 2.5 Gy received by 5 (4%). In the XRT group, preoperative radiation for 1 patient (1%) had been definitive radiation therapy for a primary esophageal tumor that irradiated the adjacent spine, rather than for metastasis. This patient was treated with 1.8 Gy per fraction to a total treatment dose of 50.4 Gy. For IGRT patients, the most common treatment regimen was 24 Gy delivered in a single fraction (40%). Single-fraction treatment of 18, 21, or 24 Gy was received by 23 patients (66%) in that group.
Wound Complications
During the follow-up period, 24 patients experienced wound complications. The frequency of each type of wound complication event in the entire group was as follows: 10 dehiscence (42%), 2 poor healing (8%), 8 infection (33%), 2 dehiscence with infection (8%), and 2 poor healing with infection (8%). Due to these complications, 12 patients required surgical debridement with or without wound closure.
Of the 24 events, 22 developed after XRT, and 2 developed after hypofractionated IGRT. The 6-month cumulative incidence of wound complication was 17% (95% CI 10%-23%) and 6% (95% CI 0%-14%) for patients treated with preoperative conventional XRT and IGRT, respectively (Fig. 1) . There was no statistically significant difference in the incidence of events between the study arms.
For the entire study group, wound complication occurred at a median of 28.5 days, or 0.95 months (range 0.4-3.9 months). Of the 24 events, 14 (58%) occurred within the first 30 days after surgery (range 13-30 days), and 10 (42%) occurred after 30 days (range 32-120 days).
Univariate analysis using competing-risks methods showed no significant difference in the occurrence of wound complication stratified by each of the patient or treatment factors evaluated. Potential predictive variables for wound complication with their respective hazard ratios (HRs) are reported in Table 5 . Univariate analyses did not reveal any statistically significant predictors of wound complication. Therefore, multivariate analyses were not performed.
The risk of wound complication did not significantly differ between the IGRT group and the XRT group (HR 0.31, 95% CI 0.08-1.30; p = 0.11) although there was a lower mean risk of wound complication for the IGRT group. There was a trend observed with radiation dose per treatment, with a lower risk of wound complication with fraction size > 300 cGy compared with 300 cGy (HR 0.27, 95% CI 0.06-1.15; p = 0.08). Estimated blood loss of > 1000 ml appeared to be associated with a higher risk of wound complication (HR 2.14, 95% CI 0.94-4.84; p = 0.07), but this also did not reach statistical significance.
For XRT patients who developed wound complications, the median duration of time between the completion of radiation and surgery was 119.5 days (range 2-5267 days). For IGRT patients, the 2 wound complications occurred with radiation completed 61 days and 538 days before surgery. For all patients, there was no difference in wound complication risk when comparing an interval of ≤ 30 days or > 30 days between radiation and surgery.
In the entire study group, 120 patients (73%) died without having developed a wound complication. No patients died as a result of wound complications. Among the XRT patients, there were 5 deaths within 30 days after surgery (range 19-29 days), and 10 deaths within 31-60 days after surgery. The 2 deaths that occurred among the IGRT patients occurred at 59 and 60 days after surgery. For the entire study cohort, death occurred at a median of 5.7 months (range 0.6-73 months). The median followup time was 9.8 months for all survivors without wound complications (range 1.6-83.5 months), 11.5 months for the XRT group (range 1.6-83.5 months), and 9.8 months for the IGRT group (range 5.1-28.9 months).
Other Complications
There were 24 patients who experienced nonwound complications within the 30 days following surgery. All nonwound complications and their frequencies are presented in Table 6 . Only 2 patients had both wound and nonwound complications.
Discussion
A systematic review of the literature has demonstrated a paucity of studies that have addressed the impact of radiation therapy on wound healing after spine surgery. 9 To our knowledge, this is the first study to investigate the effect of both conventional and hypofractionated dose schedules on the development of wound complications in the setting of spinal metastasis. This study also pres- ents the largest cohort of patients examined primarily for wound complications following preoperative radiation. While there are a few studies that have explored the effects of radiation on complications after spine surgery, radiation and its impact on wound complications was not the primary focus. Therefore, these studies typically do not provide detailed information regarding the timing of radiation before surgery, nor dose and fractionation of the radiation treatments received, making it difficult to draw clear conclusions to help guide clinical recommendations. The rates of wound complication in our study were 17% and 6% for patients receiving preoperative XRT and IGRT, respectively. These rates are lower than those reported in the literature, which tend to vary widely. The wide range of reported wound complication rates in the literature likely reflects heterogeneity of patients studied with regard to surgical, radiation, and systemic therapy exposures. The diversity of reported complications after surgery and radiation is caused by such variables as total dose administered, the time during which the radiation was administered, and its proximity to the surgery. Ghogawala et al. reported a 32% rate of dehiscence or infection in patients who had a history of receiving preoperative radiation, compared with 12% for patients who underwent surgery alone; this difference was statistically significant. 4 Of note, 13 of the 28 patients who had preoperative radiation received this therapy within 7 days of surgery due to neurological deterioration during treatment that prompted emergency surgery. For these patients, the wound complication rate was actually higher, 46% versus 20%, for those patients who received radiation more than 7 days before surgery. For the patients in the latter group, the authors did not report any further specifics regarding the timing of radiation therapy and surgery. The authors did not report radiation dose and fractionation details for any of the patients. The relatively high rates of wound complications in their investigation may be due to the fact that nearly half of the patients received radiation therapy within 7 days of surgery, and may also reflect differences in surgical practice over the relatively historic study period from 1970 through 1996.
Sundaresan et al. noted that, in their experience, patients treated by previous radiation and/or chemotherapy had a statistically significant doubling of the total complication rate from 16% to 36%, yet the authors did not provide details of the specific rate of wound complications, nor the preoperative radiation or chemotherapy exposure history. 15 Wise et al. evaluated risk factors for complications after surgery for spine metastasis and found that all wound complications (which they defined as superficial or deep wound infections) that occurred in the study group were in patients who had undergone preoperative radiation, but again, no further information regarding the specifics of radiotherapy was provided. 17 An important difference between IGRT and conventional radiotherapy is the volume of normal tissue irradiated at high doses. IGRT is highly conformal, creating high dose gradients at the edge of the PTV, minimizing the dose to tissues overlying the operated spine. However, our lower rates of wound complication could be explained by multiple factors. The retrospective nature of this study is a limitation because wound complications could potentially be underreported if patients sought evaluation and treatment outside of the MSKCC system. Although this would be unlikely given the pattern of integrated multidisciplinary care at MSKCC, this possible attrition could not be accurately quantified. Unlike the aforementioned studies, our investigation represents a more contemporary surgical cohort that spans from 1999 to 2010. Improvements in surgical techniques and practice could help account for lower complication rates. In addition, our study involved patients who were largely operated on by 1 neurosurgeon (M.H.B.) who has particular expertise in spine surgery.
The effect of ionizing radiation on normal tissues is affected by the total radiation dose, dose fraction size, total volume treated, and the elapsed time during irradiation, with these factors intimately interrelated. 2 Our study did not identify any radiation factors that significantly predicted wound complications. The rates of wound complication resulting from XRT and IGRT did not differ. A possible lower average risk of wound complications in the highdose hypofractionated IGRT arm versus the conventionally fractionated XRT arm was suggested by an HR of 0.31 (95% CI 0.08-1.3, p = 0.11). Nonetheless, IGRT showed a trend toward an association with a lower risk of wound complication (HR 0.27, 95% CI 0.06-1.15; p = 0.08).
These results run counter to what might be expected based upon animal studies. In a mouse model, Gorodetsky et al. demonstrated that the effect of single-fraction radiation on wound strength recovery was dependent on dose per fraction when administered immediately before wounding of the skin. 7 The threshold for dose response was approximately 8 Gy, with a linear dose response up to approximately 20 Gy, at which the maximum decrease in wound strength was observed. Higher doses of up to 26 Gy showed no further decrease in wound strength.
The lack of difference in wound complication rates between the XRT and IGRT groups could be explained, in part, by the significantly different number of vertebral bodies irradiated, with a mean of 4.6 and 1.8 vertebral bodies, respectively (p < 0.0001). For this study, the number of vertebral bodies targeted included those vertebral bodies within the radiation ports for XRT patients, and those vertebral bodies included in the PTV for IGRT patients. This definition was used because XRT patients do not have calculated PTVs because treatment planning is not required, thus precluding direct comparison of PTVs between groups. For a given dose of radiation, normal tissue tolerance is generally believed to decrease when larger volumes are irradiated. IGRT patients would predictably have fewer vertebral bodies irradiated because The IGRT group exhibited an approximately 70% decrease in wound complication risk compared with the XRT group. Although the magnitude of the hazard ratio is large, this did not reach statistical significance. Because all of the wound complication events occurred within 4 months of surgery and the median survivor follow-up was longer than 10 months, the study should have provided adequate follow-up to capture the wound complication events. However, the overall number of wound complication events was very small in the entire group and particularly in the IMRT group, leading to a large likelihood of Type II error. A much larger number of patients would have to be accrued in the study to provide adequate power of the tests. This may need to be done through a multicenter study, because analysis of patients treated at our institution over the course of 11 years failed to reach adequate power.
The effect of the time interval between radiation therapy and surgery could not be fully explored in this study. Patients in this study must have completed at least 9 Gy of radiation therapy before surgery, and this consequently led to the exclusion of some patients who had started but discontinued radiation therapy at < 9 Gy for emergency surgery. There were 9 patients in this study who received radiation therapy within 7 days of surgery, 6 patients within 8-14 days of surgery, and 8 patients within 15-28 days of surgery. The potential effect of these shorter time intervals could not be fully assessed due to the small number of patients having had radiation therapy close to surgery, and the even smaller number of patients among them who developed wound complications. Of the 23 patients who received radiation therapy within 30 days of surgery, only 4 developed wound complications. We did assess the effect of radiation < 30 days and ≥ 30 days before surgery, and no difference in wound complication occurrence was found (p = 0.59).
Results of our study regarding other clinical factors that may predict wound complications were generally consistent with the existing literature. Age greater than 62 years appeared to have a potentially adverse effect on wound healing on average (HR 1.9, 95% CI 0.84-4.32; p = 0.13).
The perioperative nutritional status of surgical patients is an important predictor of surgical morbidity, complication rates (particularly wound healing), length of hospitalization, and favorable surgical outcome. 10 Protein deficiency results in impaired biological response to wound healing but also impaired cell-mediated immunity resulting in lowered host resistance. Patients with malignancy often have multiple risk factors for nutritional compromise, such as advanced age, anorexia, chemotherapy-induced nausea, and the catabolic state often observed in malignancy. A study conducted at the Veterans Affairs Medical Center found serum albumin to be a predictor of noncardiac surgical morbidity and death. 5 McPhee et al. found a significant association of hypoproteinemia but not hypoalbuminemia with wound breakdown and infection. 12 Ghogawala et al. 4 did not find albumin to be associated with wound complications. In our study, we did not find preoperative albumin level to be predictive of wound complications. Lymphopenia is also considered to be reflective of protein malnutrition. It may also reflect bone marrow suppression caused by systemic therapy often observed in the cancer patient population. McPhee et al. 12 and Ghogawala et al. 4 did not find lymphopenia to be significantly associated with wound breakdown, nor did we in this study.
Estimated blood loss greater than 1 L may be related to higher risk of wound complication, which in our study showed a trend toward statistical significance (p = 0.07). This finding is similar to the study by McPhee et al., 12 which found that patients with wound infection or dehiscence also tended to have higher intraoperative blood loss.
Some of this study's variables of interest could not be assessed for a relationship with wound complications in this study. The KPS score within 2 weeks of surgery was not evaluated because it was documented in the medical record for only 50% of patients. The effect of neurological status in our study also could not be fully assessed. We approximated neurological status by ambulatory status at the time of surgery, whereas other investigations have evaluated the preoperative Frankel grade. 3, 11 The Frankel grading system is not used at MSKCC, and we therefore cannot compare our findings to those that have been published. We did not find ambulatory status to be predictive of wound complications.
Due to the heterogeneity of tumor histology within this patient cohort, histology could not be evaluated as a predictive factor for wound complications. There were other variables that could not be investigated due to homogeneity of the patient population. These variables include perioperative steroid use, posterior surgical approach, and the use of stabilization hardware, each of which was present in more than 90% of the patient population. Corticosteroid use in the preoperative and early postoperative period appears to be associated with an increase in wound complications. 17 Spinal instrumentation increases the length of the wound and possibly increases wound tension, which may increase the risk of wound complication. Ghogawala et al. found a 42% rate of wound complications for patients with spinal instrumentation versus 25% in those without instrumentation, although this difference was not significant (p = 0.12).
IGRT patients than XRT patients in this study because 2 courses of preoperative radiation was cause for study exclusion. Many patients undergoing IGRT have undergone a prior course of radiation therapy because that is one of the indications for its appropriate use.
The relatively smaller number of IGRT patients and potential selection biases preclude a meaningful comparison of outcomes such as local control and survival between the 2 radiation groups, and these outcomes were not evaluated. Potential selection biases include differences in tumor histology and overall prognosis. The 2 radiation groups were not comparable in terms of tumor histology, with IGRT patients more likely having radioresistant tumors than XRT patients. Survival differences may therefore reflect differences in the natural history and available treatment options for the predominant tumor histologies found in each of the groups. Having received radiation therapy from 2003 onwards, IGRT patients may have also benefited from improved systemic therapies developed in more recent years. In addition, IGRT is more often recommended for patients having more favorable prognostic features such as good performance status, viable systemic therapy options, and oligometastatic rather than more widely disseminated disease. Lastly, IGRT patients were more recently treated and therefore have shorter followup times than the XRT group.
The main strength of this study was the ability to compare wound complication rates occurring with different preoperative dose fractionation exposures in the setting of consistent radiation and surgical techniques, and in a relatively large patient cohort. The limited heterogeneity of radiation and surgery treatment factors allowed for a more meaningful examination of wound complication rates. Unlike other studies that comprise the limited literature addressing this clinical question, this study evaluated detailed radiation factors of dose and timing.
Conclusions
Contrary to existing clinical bias, we did not find a significant difference in wound complication rates occurring in patients receiving conventionally fractionated or high-dose hypofractionated radiation before undergoing spine surgery. Although there may be confounding factors that could account for this lack of apparent dose response with wound complication, the important finding of this study is that preoperative high-dose hypofractionated radiation is associated with clinically acceptable rates of wound morbidity.
